FDA
approval
· 2013-03-29
FDA Approved: ALYACEN 1/35 — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
Summary
FDA approved a supplemental application for ALYACEN 1/35 (norethindrone and ethinyl estradiol) from Glenmark Pharmaceuticals Inc., USA, authorizing its marketin…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ALYACEN 1/35 (NORETHINDRONE AND ETHINYL ESTRADIOL)